GtoPdb Ligand ID: 9412

Synonyms: AZD7986 | compound 30 [1] | INS 1007 | INS1007
Compound class: Synthetic organic
Comment: Brensocatib (formerly AZD7986) is reported as a second generation, oral, selective and reversible inhibitor of dipeptidyl peptidase 1 (DPP1; a.k.a. cathepsin C) [1]. Cathepsin C is required for the activation of proinflammatory neutrophil serine proteases, making this enzyme a drug target whose pharmacological inhibition has potential in the treatment of diseases such as chronic obstructive pulmonary disease (COPD) which is driven in part by excessive neutrophil activation and dysregulated neutrophil elastase activity. The compound was originally developed by AstraZeneca, but is now being progressed by Insmed.
2D Structure
Click here for structure editor
Physico-chemical Properties
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 6
Topological polar surface area 109.29
Molecular weight 420.18
XLogP 2
No. Lipinski's rules broken 0
Canonical SMILES N#CC(Cc1ccc(cc1)c1ccc2c(c1)n(C)c(=O)o2)NC(=O)C1CNCCCO1
Isomeric SMILES N#C[C@H](Cc1ccc(cc1)c1ccc2c(c1)n(C)c(=O)o2)NC(=O)[C@@H]1CNCCCO1
InChI InChI=1S/C23H24N4O4/c1-27-19-12-17(7-8-20(19)31-23(27)29)16-5-3-15(4-6-16)11-18(13-24)26-22(28)21-14-25-9-2-10-30-21/h3-8,12,18,21,25H,2,9-11,14H2,1H3,(H,26,28)/t18-,21-/m0/s1
Compound class Synthetic organic
International Nonproprietary Names
INN number INN
11097 brensocatib
AZD7986 | compound 30 [1] | INS 1007 | INS1007
Database Links
GtoPdb PubChem SID 328083514
PubChem CID 118253852
Search Google for chemical match using the InChIKey AEXFXNFMSAAELR-RXVVDRJESA-N
Search Google for chemicals with the same backbone AEXFXNFMSAAELR
Search PubMed clinical trials brensocatib
Search PubMed titles brensocatib
Search PubMed titles/abstracts brensocatib
Search UniChem for chemical match using the InChIKey AEXFXNFMSAAELR-RXVVDRJESA-N
Search UniChem for chemicals with the same backbone AEXFXNFMSAAELR